PTSD Trial, Recruiting NCT05646732 Sponsor: Allyson Rosen Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05646732
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 55 years old
  • People who are able to have a specific type of brain stimulation test called single pulse TMS performed safely and with a measurable response
  • People who are able to safely and comfortably undergo both an MRI scan and TMS (a type of non-invasive brain stimulation)
  • People who are able to read, understand, and willingly sign a consent form before any study procedures begin
  • People who have been diagnosed with PTSD according to standard diagnostic guidelines (DSM-5), confirmed through a structured clinical interview called the CAPS-5
  • People who are able to keep their medication routine stable between two brain scanning sessions

Who may not be able to join:

  • People for whom an MRI scan would not be safe or comfortable, as determined by the centre conducting the scans
  • People for whom TMS would not be safe or comfortable, including anyone with a history or condition that increases risk from this procedure
  • People with significant memory or thinking difficulties, as measured by a standard cognitive assessment called the MoCA
  • People whose primary condition causing significant daily difficulty is something other than PTSD, or whose other medical or mental health conditions would make it unclear whether symptoms are due to PTSD (confirm with trial site)
  • People who urgently need a level of care that would make participating in the study impossible
  • People currently taking medications that raise the risk of seizures or that affect blood flow responses in the brain
  • People with any other condition that could prevent them from completing the study or make the results difficult to interpret

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Allyson C Rosen, Ph.D., PAVIR/Palo Alto VAHCS/Stanford University

Phone: 6504935000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Allyson Rosen
Registry
ClinicalTrials.gov
Start date
2 August 2023
Est. completion
31 January 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Resting-State fMRI Connectivity; FMRI BOLD Response; Changes in Connectivity after cTBS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov